惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

D
Docker
爱范儿
爱范儿
人人都是产品经理
人人都是产品经理
博客园 - 司徒正美
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
量子位
罗磊的独立博客
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
小众软件
小众软件
C
Cybersecurity and Infrastructure Security Agency CISA
Cyberwarzone
Cyberwarzone
大猫的无限游戏
大猫的无限游戏
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
雷峰网
雷峰网
Simon Willison's Weblog
Simon Willison's Weblog
The Cloudflare Blog
博客园 - 三生石上(FineUI控件)
D
Darknet – Hacking Tools, Hacker News & Cyber Security
C
Cyber Attacks, Cyber Crime and Cyber Security
博客园_首页
博客园 - 叶小钗
V
Vulnerabilities – Threatpost
T
The Exploit Database - CXSecurity.com
T
Tailwind CSS Blog
IT之家
IT之家
博客园 - 聂微东
Spread Privacy
Spread Privacy
V2EX - 技术
V2EX - 技术
S
Security Affairs
宝玉的分享
宝玉的分享
V
V2EX
C
Cisco Blogs
博客园 - Franky
美团技术团队
酷 壳 – CoolShell
酷 壳 – CoolShell
月光博客
月光博客
S
Securelist
J
Java Code Geeks
Webroot Blog
Webroot Blog
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
P
Proofpoint News Feed
Last Week in AI
Last Week in AI
L
LINUX DO - 热门话题
NISL@THU
NISL@THU
WordPress大学
WordPress大学
W
WeLiveSecurity
T
Threatpost
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
腾讯CDC
阮一峰的网络日志
阮一峰的网络日志

Stocks Fundamentals Analysis India | The HinduBusinessLine

Who Am I? June 21, 2026 Shyam Metalics: What Should Investors Do? Turtlemint Fintech Solutions IPO: Should You Subscribe? Covers for Cancer Treatment Wonderla, V-Guard, Havells, Voltas, UBL, Blue Star, Emami: Hot Summer, Cold Stocks? Why Buy This Luxury Hotel on Dips Who Am I? June 14, 2026 Polycab India: What Should Investors Do? Kotak Mahindra Bank: Good time to relook? Who Am I? June 7, 2026 Cipla: Tonic For The Patient Investor JSW Steel: Will plans to double capacity boost stock price? Emami stock: Why this FMCG stock is a buy near its 52-week low Who Am I? May 31, 2026 Medanta: What Should Investors Do? Should investors buy HDFC Bank now? SpaceX IPO and the Big Bang Bubble Who Am I? May 24, 2026 Simply Put: Interest Coverage Ratio Who Am I? May 17, 2026 What They Say on Their India Plans SRF: On The Road to Recovery Godrej Agrovet Accumulate Call Palm Oil Animal Nutrition Outlook The Ramco Cements: What Should Investors Do? Nifty 50, Nifty 500: PE multiples can be the same number yet poles apart What They Say on Their India Plans Who Am I? May 10, 2026 Who Am I? May 3, 2026 What They Say on Their India Plans Wait for the fog to clear first! Steel Authority of India: With SAIL shares at a 15-year high, what should investors do? Sun Pharma-Organon deal: Outlook is mixed Banking on valuation comfort Jyothy Labs: Why the stock is a buy after 30 pc drop in last 1 year What They Say on Their India Plans Who Am I? April 26, 2026 HDFC Bank: Key takeaways for investors from Q4 results Narayana Health: Heart At The Right Place Who Am I? April 19, 2026 Citius TransNet InvIT IPO: Should you apply? What the numbers say The sector call illusion Caplin Point: Consolidating before the next leg of growth Who Am I? April 12, 2026 Banking on a transformation Who Am I? April 5, 2026 Zydus Lifesciences: Bridging the gap What should investors do about Bosch shares New India Assurance stock call: Should investors accumulate on dips? Will this engineering behemoth stock fix the dented investor confidence? Who Am I? March 29, 2026 Equities, Bonds, Commodities, Currencies et al: How They Fare Three Weeks into the US-Iran War Navin Fluorine: What Should You Do? Who Am I? March 22, 2026 HDFC Bank’s Part-time Chairman resigns: What investors need to know CMPDI IPO Review: Subscribe to Central Mine Planning & Design Institute Issue? Who Am I? March 15, 2026 Ambuja Cements: What Should You Do? IHCL stock: Accumulate on dips after correction Raajmarg Infra Investment Trust IPO: Should you invest? AMC stocks defy markets, enjoy outperformance and premium valuations United Breweries Hold Call: Margin Gains Help, But Valuation Remains Rich PG Electroplast stock: Hot Summer, Hotter Sales Who Am I? March 8, 2026 Should you subscribe to Sedemac Mechatronics IPO? Who Am I? March 1, 2026 ITC Hotels: Accumulate on dips as valuation cools and asset-light growth gathers pace Lumax Industries: Should You Book Profit After The Small-Cap’s Stellar Run? What They Say on Their India Plans DLF: A Premium Residential and Commercial Spaces Play Clean Max IPO: Should You Subscribe? Who Am I? Feb 22, 2026 Tata Motors: What investors need to know about the demerged commercial vehicle business Who Am I? Feb 15, 2026 Sun Pharma: What should investors do? What the merger of PFC and REC means for investors India Inc delivers well in Q3 FY26 NBCC: A Solid Construction Play on Government Capex Fractal Analytics IPO review: Valuation looks demanding amid AI disruption Who Am I? Feb 8, 2026 How market fares around Budgets Dr. Reddy and Cipla: Growth in the post-Lenalidomide era for pharma stocks Who Am I? Feb 1, 2026 Who Am I? Jan 25, 2026 Should You Consider Buying Bank of Maharashtra’s Stock? What investors need to glean from HDFC Bank’s Q3 results Neuland Laboratories: What Should Investors Do? Who Am I? Jan 18, 2026 Shadowfax IPO Review: Fast Growth, Thin Margins — Subscribe or Wait? Amagi Media Labs IPO: Are valuations outpacing profits for this SaaS company? Nexus Select Trust: Yielding More on Urban Consumption Who Am I? Jan 11, 2026 BCCL IPO: Cheap on paper, costly in a downcycle; why Coal India may be the smarter pick Mankind Pharma: Finding synergies amidst transformation What Should Investors Do About The PNB Housing Finance Stock? Who Am I? Jan 4, 2026 Chalet Hotels: Buy, Sell or Hold? Shree Cement: What Should Investors Do? Who Am I? Dec 28, 2025 Decoding Life Insurers ICICI Prudential Life: Is The Least Expensive Life Insurer A Good Bet Now?
SAMHI Hotels stock call: Accumulate on dips
By Kumar Shankar Roy · 2026-05-10 · via Stocks Fundamentals Analysis India | The HinduBusinessLine

Amid the West Asia war-related disruption and impact on economy, inflation and stock markets, the structural long-term cycle in India’s hotel sector continues to remain favourable. Given the demand-supply gap, with business travel, meetings and exhibitions, and premium leisure-led business, demand is expected to outpace fresh room supply in key markets over the next few years.  In this context, SAMHI Hotels requires a re-look.

When branded hotel ownership firm SAMHI Hotels came out with its IPO in September 2023 at ₹126 a share, our view was clear: investors can avoid the IPO.

The hesitation was not because the business lacked merit. SAMHI had scale, global hotel brands (Marriott, Hyatt, IHG), urban business-hotel exposure and an acquisition-led turnaround model. The concern was that the company was still loss-making, carried high debt (proforma at the time of IPO: over ₹2,800 crore, debt/adj. EBITDA 11x) and finance costs (then at 59 per cent of revenue) were eating into the benefits of a strong hotel upcycle.

Nearly three years later, the stock has had a full cycle of enthusiasm and correction. It touched a peak of about ₹255 (BSE), and a bottom of ₹120 in 2025, and now trades at ₹157.45. From the IPO price, it is still up 25 per cent, better than the broader Sensex (up 16 per cent), but has underperformed larger listed hotel peers such as Indian Hotels (up 56 per cent), EIH (up 41 per cent) and Chalet Hotels (up 34 per cent). SAMHI’s 38 per cent correction from peak, coupled with improving fundamentals, makes the risk-reward more interesting now.

At the current price and based on FY27 consensus earnings estimate per Bloomberg, SAMHI trades at a one-year forward PE of 14.6 times, less than two times price-to-book and around 9.3 times EV/EBITDA (was 16x during IPO). Its forward P/E now is at around 40 per cent discount to its own two-year average of about 24 times.

Having said that, the stock is not without risk, but the business is no longer the same leveraged, loss-making IPO story. Investors with a three-five-year perspective can accumulate the stock on dips, but only in small quantities, given the relatively-small market capitalisation of around ₹3,500 crore and still-meaningful debt (debt/adj. EBITDA at 4x), although leverage risk is significantly lower than at the time of IPO.

What has changed

SAMHI Hotels currently has a portfolio of over 6,500 rooms, with the break-up being 2,500-plus rooms in upper upscale and upscale segment, upper mid-scale 2,010 rooms, and the rest in mid-scale segment. Out of this, about 4,900 rooms are operational across 31 hotels.

The company’s business model encompasses its acquisition and turnaround-led approach, resulting in lower cost per key vis-a-vis average for hotels in India. SAMHI leverages the power of strong hotel brands, enjoys a strong demand base thanks to presence in high-density micro-markets. Its proprietary tools (SAMHIIntel, SAMConnect) help drive performance and efficiency.

The first major change is turnaround in bottomline profitability. At the time of the IPO, SAMHI had scaled up but had not shown sustained profitable growth (losses in FY21, FY22 and FY23). That has changed. The company reported adj. PAT of ₹99.1 crore in FY25 and over ₹216 crore for trailing twelve months (TTM). Due to low base, quarterly PAT numbers optically show sharp growth. The direction is important, quarterly PAT has remained positive since Q4FY24.

The second change is debt and interest cost. This was the biggest concern during the IPO. Debt has not disappeared, but it has moved in the right direction. At the time of the IPO, SAMHI wanted to cut loans, especially the high-cost ones. Total debt has come down from around ₹2,690 crore in FY23 to about ₹1,726 crore in the TTM period. Finance cost declined by around one-third year on year to ₹40.3 core in Q3FY26. Loan interest rate is now 8.3 per cent vs. 9.7 per cent in FY24. Annualised interest cost has also fallen 38 per cent to about ₹125 crore in December 2025. SAMHI should be able to fund its annual capex outlay, estimated at ₹180-210 crore, primarily through internal accruals.

The third change is operating momentum. SAMHI’s Q3FY26 same-store Revenue Per Available Room (RevPAR) grew 13.3 per cent, while total income rose 16.2 per cent. For 9MFY26, total income grew 13.5 per cent and consolidated EBITDA rose 15.2 per cent. The company did face a GST-related margin hit after the removal of input tax credit for hotels with room rates below ₹7,500, but even after this impact, consolidated EBITDA margin in Q3 stood at a healthy 36.9 per cent. The management expects GST impact to gradually fade in the medium term.

The fourth change is portfolio quality. SAMHI is moving up the chain. Ongoing rebranding and renovations are expected to increase the revenue share of upper upscale and upscale hotels from about 42 per cent now to about 60 per cent after projects are completed. This matters because the premium portfolio earns much higher room rates. For instance, upper upscale and upscale average room rate (ARR) stood at ₹12,537, compared with ₹7,904 for upper mid-scale and ₹4,385 for mid-scale in the third quarter.

A fifth, and newer, positive is SAMHI’s move into a more capital-light growth route. Its proposed 70 per cent acquisition (for ₹47 crore) of luxury hospitality platform RARE India gives it exposure to experiential leisure without buying the underlying hotels. RARE gives access to 67 hotels and 990 rooms across India, Nepal and Bhutan, covering curated assets such as forts, palaces, hill retreats and wildlife lodges. It has no hospitality assets. RARE currently earns B2B listing fees, but can build B2C commission income upon integration with Marriott’s ecosystem. This is important because one concern with SAMHI has been its acquisition-led model. RARE does not change the core business overnight, but it adds optionality. RARE can deliver higher returns, with potential B2C revenue from FY27.

What needs watching

Debt remains the main risk. The direction is better, but absolute debt is still high relative to profits and market capitalisation. A company with a market value of about ₹3,500 crore and debt of ₹1,726 crore (net debt ₹1,450 crore) cannot be treated like a risk-free hotel compounder such as IHCL. Any slowdown in ARR growth, occupancy or asset ramp-up can again expose the balance sheet.

The second risk is execution. The company has a large pipeline, including W Hyderabad (170 rooms), Westin Whitefield (200 rooms), Navi Mumbai (700 rooms), Hyderabad Financial District (260 rooms) and multiple rebranding projects. These can lift revenue and later margins as operating leverage kicks in, but delays or cost overruns can hurt. FY27 may also be more about ramp-up of recent additions than large new openings. The pipeline consists of a mix of new hotel openings, rebranding of existing assets and expansions of currently operational properties.

The third risk is that some positives are still assumptions. RARE’s B2C platform is promising, but the commission income is largely untapped today. Marriott integration, higher occupancy, new owner onboarding and platform scale-up have to be delivered. It should be viewed as attractive optionality, not the base reason to buy the stock.

The fourth risk is cyclicality. Hotels are enjoying a strong upcycle, helped by limited room supply, business travel, MICE (Meetings, Incentives, Conferences, and Exhibitions), premium pricing and higher occupancies. If the cycle weakens, smaller leveraged players can correct faster than stronger peers.

SAMHI deserves a better view today than it did at IPO. The original caution was valid because the company was loss-making, highly leveraged and still proving its model. But the facts have changed. It is profitable, finance costs are falling, credit metrics have improved, premiumisation is underway and valuation has corrected sharply.

Valuation discount after sharp correction

Profits now replacing IPO-era losses

Premiumisation plus asset-light leisure optionality

Published on May 9, 2026